Canopy Growth (CGC) Cash & Current Investments (2017 - 2025)
Canopy Growth's (CGC) quarterly Cash & Current Investments came in at $148.7 million in Q4 2025, up 16.47% year-on-year from $127.7 million in Q4 2024, and up 51.46% quarter-over-quarter from $98.2 million in Q3 2025.
Canopy Growth (CGC) Cash & Current Investments (2017 - 2025) Analysis & Trends
Canopy Growth has disclosed Cash & Current Investments across 9 years of filings, most recently posting $148.7 million for Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $148.7 million, up 16.47% year-over-year; the trailing twelve-month figure through Dec 2025 was $148.7 million (up 16.47% YoY), and the FY2025 annual result was $83.7 million, up 28.11% from the prior year.
- Cash & Current Investments came in at $148.7 million for Q4 2025 at Canopy Growth, up from $98.2 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $954.6 million in Q2 2022 to a low of $12.7 million in Q2 2025.
- The 5-year median for Cash & Current Investments is $306.2 million (2023), against an average of $372.5 million.
- Across the five-year window, Cash & Current Investments jumped 104.37% in 2022 and sank 91.11% in 2025, its largest moves.
- Canopy Growth's Cash & Current Investments stood at $497.7 million in 2021, then advanced by 16.83% to $581.4 million in 2022, then tumbled by 76.48% to $136.8 million in 2023, then slipped by 6.65% to $127.7 million in 2024, then rose by 16.47% to $148.7 million in 2025.
- The last three Cash & Current Investments figures came in at $148.7 million (Q4 2025), $98.2 million (Q3 2025), and $12.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Canopy Growth | 11.27 Mn | -137.42 Mn | 15.39 Mn | 148.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 148.69 Mn |
| Sep 30, 2025 | 98.18 Mn |
| Jun 30, 2025 | 12.67 Mn |
| Mar 31, 2025 | 83.69 Mn |
| Dec 31, 2024 | 127.67 Mn |
| Sep 30, 2024 | 172.93 Mn |
| Jun 30, 2024 | 142.52 Mn |
| Mar 31, 2024 | 65.33 Mn |
| Dec 31, 2023 | 136.76 Mn |
| Sep 30, 2023 | 187.20 Mn |
| Jun 30, 2023 | 425.13 Mn |
| Mar 31, 2023 | 571.95 Mn |
| Dec 31, 2022 | 581.44 Mn |
| Sep 30, 2022 | 582.01 Mn |
| Jun 30, 2022 | 954.63 Mn |
| Mar 31, 2022 | 622.28 Mn |
| Dec 31, 2021 | 497.70 Mn |
| Sep 30, 2021 | 651.29 Mn |
| Jun 30, 2021 | 467.11 Mn |
| Mar 31, 2021 | 921.24 Mn |